Log in

NASDAQ:RELVReliv International Stock Price, Forecast & News

-0.26 (-6.65 %)
(As of 08/14/2020 04:00 PM ET)
Today's Range
Now: $3.65
50-Day Range
MA: $3.72
52-Week Range
Now: $3.65
Volume23,153 shs
Average Volume20,828 shs
Market Capitalization$6.37 million
P/E RatioN/A
Dividend YieldN/A
Reliv' International, Inc. develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. Its nutritional supplements primarily include Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form. The company markets and sells its products through a network of distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Singapore, and the United Kingdom. Reliv' International, Inc. was founded in 1984 and is headquartered in Chesterfield, Missouri.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:RELV



Sales & Book Value

Annual Sales$35.06 million
Cash Flow$0.07 per share
Book Value$6.36 per share


Net Income$-440,000.00


Market Cap$6.37 million
Next Earnings DateN/A
OptionableNot Optionable
-0.26 (-6.65 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RELV News and Ratings via Email

Sign-up to receive the latest news and ratings for RELV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Reliv International (NASDAQ:RELV) Frequently Asked Questions

How has Reliv International's stock price been impacted by Coronavirus?

Reliv International's stock was trading at $3.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RELV stock has increased by 12.3% and is now trading at $3.65.
View which stocks have been most impacted by COVID-19

How were Reliv International's earnings last quarter?

Reliv International, Inc (NASDAQ:RELV) released its quarterly earnings results on Friday, May, 15th. The company reported $0.38 earnings per share (EPS) for the quarter. The company earned $10.28 million during the quarter. Reliv International had a negative net margin of 1.13% and a negative return on equity of 3.52%.
View Reliv International's earnings history

Has Reliv International been receiving favorable news coverage?

News articles about RELV stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Reliv International earned a news impact score of -1.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days.
View the latest news about Reliv International

Are investors shorting Reliv International?

Reliv International saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 2,100 shares, an increase of 133.3% from the June 15th total of 900 shares. Based on an average trading volume of 15,500 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.2% of the company's shares are short sold.
View Reliv International's Short Interest

Who are some of Reliv International's key competitors?

What other stocks do shareholders of Reliv International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reliv International investors own include Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Gold Standard Ventures (GSV), Gold Standard Ventures (GSV), Primo Water (PRMW), Rite Aid (RAD), RadNet (RDNT), Ring Energy (REI), Ring Energy (REI) and VIVUS (VVUS).

Who are Reliv International's key executives?

Reliv International's management team includes the following people:
  • Mr. Robert L. Montgomery, Co-Founder & Chairman (Age 77)
  • Dr. Carl W. Hastings, Vice Chairman, Chief Scientific Officer & Member of the Scientific Advisory Board (Age 77)
  • Mr. Thomas W. Pinnock III, Pres of Sales & Marketing (Age 68)
  • Mr. Ryan A. Montgomery, CEO, Pres & Director (Age 45)
  • Mr. Steven D. Albright CPA, Sr. VP & CFO (Age 57)

What is Reliv International's stock symbol?

Reliv International trades on the NASDAQ under the ticker symbol "RELV."

How do I buy shares of Reliv International?

Shares of RELV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Reliv International's stock price today?

One share of RELV stock can currently be purchased for approximately $3.65.

How big of a company is Reliv International?

Reliv International has a market capitalization of $6.37 million and generates $35.06 million in revenue each year. Reliv International employs 156 workers across the globe.

What is Reliv International's official website?

The official website for Reliv International is www.reliv.com.

How can I contact Reliv International?

Reliv International's mailing address is 136 CHESTERFIELD INDUSTRIAL BLVD, CHESTERFIELD MO, 63006. The company can be reached via phone at 636-537-9715 or via email at [email protected]

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.